PSFC Strategic Roadmap

Collective Philanthropy in the Psychedelic Field

Letter from the Board

Dear PSFC community,

We are thrilled to share this strategic roadmap for collective philanthropy in the psychedelic field, to guide our actions in the years ahead. It reflects insights from more than 100 experts in the psychedelic field, in addition to numerous PSFC members, to all of whom we are deeply grateful.

Psychedelic research restarted in the 1990s following decades of dormancy in the hope that it would lead to legal therapeutic access. In 2017, we were inspired to found PSFC when the promise of making a psychedelic into a prescription medicine had come into sharp focus. Seven years later, the field has made remarkable progress toward the goal of expanding access to psychedelic healing to all who can benefit.

We are so excited by the growing body of evidence that will help us to realize the benefits of psychedelic substances, and to responsibly address their risks. At the same time, the path toward medical and state-regulated access to psychedelics has brought surprises and setbacks. Notably, this summer, the FDA declined to approve Lykos Therapeutics’ application for MDMA-assisted therapy. Since then, Lykos has met with the FDA and set a path forward. Nonetheless, the FDA’s disappointing decision created a new imperative for the field to come together in a broad coalition of funders, operators, and advocates, and to level up our collaboration with eyes firmly on our long-term goals. It is in this spirit that we share the roadmap as a rallying point for philanthropy in service of broadening safe and equitable access to psychedelic healing.

We crafted this roadmap in response to a request from PSFC’s membership for guidance on collective philanthropy. It outlines a strategy for advancing opportunities that are essential for the long-term success of the field, and balances a coherent set of core priorities with the acknowledgment of many other promising efforts. And it makes clear that the work ahead requires a coordinated funding effort across diverse priorities—from research to implementation, from public education to policy reform, from access to safety, and more.

We believe this to be the most comprehensive survey ever made of activity and imperatives in the psychedelic field. However, it is inevitably incomplete, and it will always be challenged to keep up with a dynamic field. We see this roadmap as a living document, and look forward to engaging with the field broadly to act on its recommendations, while also gathering insights for its evolution. We invite you as funders to join us on the next stage of this journey. Together, this community can make a decisive contribution to the future of mental health and human wellbeing.

Sincerely,

Joe Green, Graham Boyd, Protik Basu, David Bronner, Genevieve Jurvetson & Mike Cotton
Board of Directors, Psychedelic Science Funders Collective

The current version of the Strategic Roadmap is only accessible to members of the PSFC community at this time. PSFC members, please provide your name and email below, followed by the password in the next page.

If you’re interested in learning more about PSFC and the Strategic Roadmap, please provide your name and email.

Your information will not be shared with any third parties, and will only be used to contact you if you tick the checkbox at the end of the form.